Shock for government scheme patients! Big private hospitals may exit Ayushman Bharat, know the reason

Ayushman Bharat Scheme: The central government’s ‘Ayushman Bharat Yojana’ was started in 2018, the objective of which is to provide free treatment up to Rs 5 lakh in a year to poor families. Till now lakhs of people have taken advantage of it, but according to recent news, some big private hospitals are thinking of separating themselves from this scheme.

private hospitals are moving out

According to the ET report, private hospitals are facing a lot of problems due to low treatment prices and delay in government payments. Big hospitals like Max, Fortis and Narayana Health say that running these government schemes is now proving to be a loss-making deal. At present, no hospital has directly announced its exit, but now they can reduce the number of beds for these patients or distance themselves from certain schemes. It is being estimated that in the future, the share of government schemes in the earnings of hospitals may come down from 25 percent to much less.

Private hospitals are maintaining distance

Government schemes like CGHS and ECHS are mainly for the treatment of government employees and ex-servicemen, but the rates fixed by the government are very unprofitable for hospitals. Apollo Hospitals has a very low stake in these schemes as 83 per cent of its revenue comes from direct paying or insured patients. This is the reason why hospitals are now giving more priority to those patients from whom they earn better, while they are staying away from less profitable government schemes.

Read this also-This is a big change in the Income Tax Department! This form will have to be filled immediately otherwise the government will deduct the money.

Loss of around Rs 200 crore

To improve their financial condition, private hospitals are now paying attention to those patients who pay immediately. Max Healthcare has revealed that they have suffered a loss of around Rs 200 crore due to the CGHS scheme. The main problem is the huge discounts given on medicines. For example, due to declining profits, hospitals have even stopped supplying low-margin chemotherapy drugs.